Today in News History
On July 13, several notable moments in the history of News stand out. In 1105, Rashi, French rabbi and commentator (born 1040) passed away. In 1896, August Kekulé, German chemist and academic (born 1829) passed away. In 1956, The Dartmouth workshop is the first conference on artificial intelligence. In 1969, Oleg Serebrian, Moldovan political scientist and politician was born. In 1973, Watergate scandal: Alexander Butterfield reveals the existence of a secret Oval Office taping system to investigators for the Senate Watergate Committee. In 1993, Davey Allison, American race car driver (born 1961) passed away. In 1995, Space Shuttle Discovery is launched on STS-70 to deploy the TDRS-7 satellite. In 1996, Pandro S. Berman, American director, producer, and production manager (born 1905) passed away. In 2005, Robert E. Ogren, American zoologist (born 1922) passed away. In 2024, Richard Simmons, American fitness personality and public figure (born 1948) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.
Forte Biosciences: FB102 Is Becoming A Platform Story, Not A Single-Indication Bet
Narrative Intelligence Brief
This article was published by Seeking Alpha, a source frequently categorized with a lean right bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of Seeking Alpha, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from Seeking Alpha
July 13, 2026
CSQ: Trading Below Its Historical Discount
July 13, 2026
The Triple-Factor Closed-End Fund Report, June 2026
July 13, 2026
Fast Retailing: Staying Positive After Q3 Outperformance And Upgraded Guidance
July 13, 2026
Flowserve: Treading Water
July 13, 2026
Tempus AI: The Market Is Betting On An Inflection I Can't Yet See
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
How other outlets are covering this story
Compare narratives across 26 related reports from 26 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
26 sources
Left 27%
Center 38%
Right 27%
The Motley Fool
· Jun 29, 2026
What Does the Maze Therapeutics CEO's Sale of Nearly 30,000 Shares Mean for Investors?
This clinical-stage biotech targeting kidney and metabolic diseases reported a notable insider sale, recent filings show.
Seeking Alpha
· Jul 8, 2026
A New Look At Legend Biotech: Plenty Of Upside For Carvykti
A New Look At Legend Biotech: Plenty Of Upside For Carvykti
Fortune
· Jun 21, 2026
Ezekiel Emanuel: My father lived into his 90s. He understood something many successful men miss
The wellness industry wants you obsessing over biomarkers and supplements. One physician's life offers a simpler—and more effective—blueprint for aging.
Scientific American
· Jun 29, 2026
Gene-editing startups are using CRISPR to treat diseases
A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high cholesterol to a rare muscular disorder
The Next Web
· Jun 30, 2026
Jon and Mindy Gray bet $55M on AI to catch cancer before it starts
A new institute at Penn’s Basser Center will use artificial intelligence and biomarkers to intercept hereditary cancers at their earliest stages, before they become disease. The idea behind the gift is unusual enough to need its own word. Most cancer philanthropy funds treatment, the long campaign that begins once a tumour has announced itself. Jon [] This story continues at The Next Web
E! Online
· Jun 25, 2026
Jennifer Aniston’s Vital Proteins Collagen Powder Plummets to $19
It doesn't have to be a new year to refresh your commitment to wellness, but we're taking Amazon Prime Day as a sign to do it! As a longtime supporter of Vital Proteins and their collagen powders,...
Dr. Malcolm Kendrick
· May 22, 2026
NICE and Wegovy – so much that cannot be seen
[Part two of a review on the National Institute for Health and Care Excellence (NICE). Which approved Wegovy (semaglutide) for use in preventing CV disease]. Stripping it down to basics, the key messages from the NICE report were: You may have noticed three little black boxes. Yes, redacted, redacted, and yes, well, redacted once []
Perfect Health Diet
· Jun 26, 2018
Angiex’s Upcoming Mission on the International Space Station
I think most of you know that the reason we haven’t been posting much the last three years is that Shou-Ching and I launched a biotech company, Angiex, in 2015 with the goal of creating a breakthrough cancer therapy. Our Read more » The post Angiex’s Upcoming Mission on the International Space Station appeared first on Perfect Health Diet.
Us Weekly
· Jun 26, 2026
Bethenny Frankel's 5-in-1 Glowy Foundation Is on Sale — But Only for a Few More Hours
Finding a foundation that delivers coverage without looking heavy or cakey is easier said than done. The seemingly endless search is over, thanks to Bethenny Frankel, who reminded Us why she keeps coming back to It Cosmetics CC Cream time and time again. The multitasking formula has earned more than 24,000 five-star reviews on Amazon []
UPI
· Jul 8, 2026
Ivermectin isn't a cancer miracle drug, but influencers claim otherwise -- here's how to avoid sprinting past scientific evidence
Ivermectin isn't a cancer miracle drug, but influencers claim otherwise -- here's how to avoid sprinting past scientific evidence
Investing.com
· Jul 9, 2026
Form 144 Twist Bioscience Corp For: 9 July
Form 144 Twist Bioscience Corp For: 9 July
NaturalNews.com
· Jun 26, 2026
Probiotic Supplement May Reduce Depression and Anxiety Symptoms in Older Adults, Study Finds
(NaturalNews) A small clinical trial published in the Journal of the American Geriatrics Society found that daily probiotic supplementation, when combined with stan...
Inc.com
· Jul 4, 2026
The New Anthropic Tool That Could Change How Drugs Are Developed
Introducing Claude Science, the AI platform designed to expedite the discovery of promising new therapies. Anthropic will also use it in-house to pursue innovative treatments for ‘neglected’ diseases.
The Suburban
· Jun 21, 2026
Suzanne Reisler Litwin: Showing up … for the Breakthrough T1D Walk to cure type 1 diabetes
Suzanne Reisler Litwin: Showing up … for the Breakthrough T1D Walk to cure type 1 diabetes
DNyuz
· Jun 21, 2026
I’d Rather Risk Cancer Than See AI Move This Fast
On a fall afternoon 15 years ago, I met an idealistic researcher outside a Stanford coffee shop to discuss our shared dream: using AI to detect cancer. He had wiry hair, a penchant for talking with his hands, and a reputation for brilliance. He worked at a research lab that developed early screens for cancer; []
Medical Daily
· Jun 29, 2026
6 of 12 Top-Selling Glutathione Supplements on Amazon Fail Label Claims in Independent Testing, Cata-Kor Finds
Cata-Kor, a U.S.-based nutraceutical company focused on science-informed longevity formulations, released results from independent laboratory testing of 12 top-selling glutathione supplements purchased from Amazon.com in April 2026. Of the 12 products tested, 6 failed to meet their label claims for glutathione content.
The Daily Beast
· Jun 21, 2026
MAGA Rep. Mocked Over Bonkers ‘Transgender Mice’ Bill
Justin Sullivan / Getty ImagesSouth Carolina Rep. Nancy Mace is drawing ridicule after unveiling a bill aimed at cracking down on federal funding of “transgender mice.”Mace, 48, announced her “TRANS MICE Act” legislation on X Thursday, but was swiftly hit with a Community Note suggesting she had misunderstood the research the bill seeks to target.“‘Trans mice’ refers to transgenic mice not transgender mice. Transgenic mice are defined as mice that have incorporated foreign DNA into their genome, allowing for the study of gene function and disease mechanisms, particularly in cancer research,” it read.Read more at The Daily Beast.
Futurism
· Jul 4, 2026
Peptide That Makes You Tan Linked to Skin Cancer, Doctor Warns
I don't really see a medical benefit of it at all. The post Peptide That Makes You Tan Linked to Skin Cancer, Doctor Warns appeared first on Futurism.
South Africa Today
· Jul 3, 2026
Global Fitness Highlights Its Used Treadmill Range as Summer Begins
The Gardena, California remanufacturer points home and commercial buyers toward its restored cardio lineup as the second half of 2026 begins. Global Fitness, the California seller of new, refurbished, and used gym equipment, is putting its treadmill selection front and center this June as households and training facilities across the United States plan their cardio []
Gary Taubes
· Apr 10, 2024
Substack 7: Nutrition has a Metaverse Problem
When nutritional epidemiologists conclude (as they always do) that some item of our diet or lifestyle associates with chronic disease, it’s inevitably news. Not so when methodologists point out potential, if not very disturbing problems with the epidemiology itself. This research has enormous influence on our conceptions of a healthy diet and yet the media...Read More »
Voice of Nigeria
· Jun 29, 2026
FDA Reviews Sandoz Generic Obesity Drug Applications
The U.S. Food and Drug Administration (FDA) has accepted for review two generic versions of tirzepatide developed by Swiss pharmaceutical company Sandoz, a move that could pave the way for increased competition in the rapidly expanding obesity and diabetes treatment market. If approved, the medicines would become direct competitors to Eli Lilly’s blockbuster tirzepatide brands, [] The post FDA Reviews Sandoz Generic Obesity Drug Applications appeared first on Voice of Nigeria.
The West Australian
· Jun 23, 2026
New heart ‘Band-Aid’ tech could serve as cheaper, more accessible heart transplant alternative
A groundbreaking piece of technology has been hailed as the “holy grail” of treatment for one major health issue, which could ease patients grappling with staggeringly long transplant lists.
Slate Magazine
· Jun 23, 2026
Is Donald Trump on a Wonder Weight Loss Drug? Here’s What You Need to Know.
Let us answer your questions about a slightly serious—but deeply amusing—medical mystery.
ScienceDaily
· Jul 11, 2026
Experimental drug reverses severe fatty liver disease by repairing the gut
An experimental drug called DT-109 reversed severe fatty liver disease in animal studies by repairing the gut and preventing harmful toxins from damaging the liver. The discovery could open the door to a new class of treatments for MASH and potentially other diseases tied to gut health.
Precision Nutrition
· Aug 18, 2025
Over a Tenth of Your Clients Are Dealing With IBS—And Here’s How to Help
Pinpoint IBS triggers, and find the lifestyle modifications that bring relief. The post Over a Tenth of Your Clients Are Dealing With IBS—And Here’s How to Help appeared first on Precision Nutrition.
Research Professional News
· Jul 2, 2026
‘Big changes’: Crick to stop paying for hybrid open access
Leading biomedical research institute says it will “go full in on green and gold” The post ‘Big changes’: Crick to stop paying for hybrid open access appeared first on Research Professional News.
Topics:
Related coverage for "Forte Biosciences: FB102 Is Becoming A Platform Story, Not A Single-Indication Bet": The Motley Fool — What Does the Maze Therapeutics CEO's Sale of Nearly 30,000 Shares Mean for Investors?. Seeking Alpha — A New Look At Legend Biotech: Plenty Of Upside For Carvykti. Fortune — Ezekiel Emanuel: My father lived into his 90s. He understood something many successful men miss. Scientific American — Gene-editing startups are using CRISPR to treat diseases. The Next Web — Jon and Mindy Gray bet $55M on AI to catch cancer before it starts. E! Online — Jennifer Aniston’s Vital Proteins Collagen Powder Plummets to $19. Dr. Malcolm Kendrick — NICE and Wegovy – so much that cannot be seen. Perfect Health Diet — Angiex’s Upcoming Mission on the International Space Station. Us Weekly — Bethenny Frankel's 5-in-1 Glowy Foundation Is on Sale — But Only for a Few More Hours. UPI — Ivermectin isn't a cancer miracle drug, but influencers claim otherwise -- here's how to avoid sprinting past scientific evidence. Investing.com — Form 144 Twist Bioscience Corp For: 9 July. NaturalNews.com — Probiotic Supplement May Reduce Depression and Anxiety Symptoms in Older Adults, Study Finds. Inc.com — The New Anthropic Tool That Could Change How Drugs Are Developed. The Suburban — Suzanne Reisler Litwin: Showing up … for the Breakthrough T1D Walk to cure type 1 diabetes. DNyuz — I’d Rather Risk Cancer Than See AI Move This Fast. Medical Daily — 6 of 12 Top-Selling Glutathione Supplements on Amazon Fail Label Claims in Independent Testing, Cata-Kor Finds. The Daily Beast — MAGA Rep. Mocked Over Bonkers ‘Transgender Mice’ Bill. Futurism — Peptide That Makes You Tan Linked to Skin Cancer, Doctor Warns. South Africa Today — Global Fitness Highlights Its Used Treadmill Range as Summer Begins. Gary Taubes — Substack 7: Nutrition has a Metaverse Problem. Voice of Nigeria — FDA Reviews Sandoz Generic Obesity Drug Applications. The West Australian — New heart ‘Band-Aid’ tech could serve as cheaper, more accessible heart transplant alternative. Slate Magazine — Is Donald Trump on a Wonder Weight Loss Drug? Here’s What You Need to Know.. ScienceDaily — Experimental drug reverses severe fatty liver disease by repairing the gut. Precision Nutrition — Over a Tenth of Your Clients Are Dealing With IBS—And Here’s How to Help. Research Professional News — ‘Big changes’: Crick to stop paying for hybrid open access

